Dominance of an UBA1 mutant clone over a CALR mutant clone: from essential thrombocytemia to VEXAS

Haematologica. 2021 Dec 1;106(12):3245-3248. doi: 10.3324/haematol.2021.279418.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calreticulin / genetics
  • Clone Cells
  • Humans
  • Mutation
  • Thrombocythemia, Essential* / diagnosis
  • Thrombocythemia, Essential* / genetics

Substances

  • Calreticulin

Grants and funding

Funding: this work was supported by SiRIC CURAMUS (INCA-DGOS-Inserm_12560).